Events

Capio Suture Capturing Devices and Pelvic Floor Kits 의 안전성 경고

Department of Health에 따르면, 해당 안전성 경고 는 Hong Kong 에서 Boston Scientific 에 의해 제조된 제품과 관련되어 있습니다.

이것은 무엇인가요?

안전성 경고는 의료기기 제품과 관련된 중요한 정보와 권고사항을 담고 있습니다. 물론 안전성 경고가 배포되었다고 해서 해당 제품이 무조건 안전하지 않은 제품이라는 것은 아닙니다. 보건의료업계 종사자와 의료기기 사용자들에게 배포되는 안전성 경고에는 회수(recall)도 포함될 수 있습니다. 제조사가 안전성 경고를 작성하기도 하지만, 보건당국에서 작성하는 경우도 있습니다.

데이터에 대해 더 자세히 알아보기 여기
  • 사례 유형
    Safety alert
  • 날짜
    2018-02-14
  • 사례 출판 날짜
    2018-02-14
  • 사례 국가
    Hong Kong
  • 사례 출처
    DH
  • 사례 출처 URL
    https://www.mdco.gov.hk/english/safety/recalls/recalls_20180214b.html
  • 비고 / 경고
    Hong Kong data is current through September 2018. All of the data comes from the Department of Health (Hong Kong), except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of data from the U.S. and Hong Kong.
  • 데이터 추가 비고
    Medical Device Safety Alert
  • 원인
    Medical device safety alert: boston scientific capio suture capturing devices and pelvic floor kits medical device manufacturer, boston scientific, has issued a medical device safety alert concerning its capio suture capturing devices and pelvic floor kits. the affected products are as follows: - capio slim open access suture capturing device [m0068318250] capio slim open access suture capturing device (box 5) [m0068318261] capio open access suture capturing device (box 4) [m0068311251] uphold vaginal support system [m0068317080] uphold lite with capio slim vaginal support system [m0068318170] pinnacle posterior pelvic floor repair kit [m0068317100] pinnacle lite posterior with capio slim pelvic floor repair kit [m0068318150] the manufacturer observed a gradual increasing trend in reports regarding the capio suture breakage and/or detachment of the capio suture darts from both the capio suture and the pelvic floor kit mesh assembly. the mesh assembly refers to the portion of the pelvic floor delivery system which is removed from the patient following implantation of the mesh. as a result, the manufacturer is voluntarily initiating a product advisory to the technique for use of the capio suture capturing devices and the uphold lite with capio slim vaginal support system, and pinnacle lite posterior with capio slim pelvic floor repair kits. according to the manufacturer, capio suture breakage and/or detachment of the capio suture darts occurs when higher amounts of counter-traction (tension) are placed on the capio suture or pelvic floor kit mesh assembly during deployment. the most common reported injury has been a prolonged procedure beyond anticipated/expected duration. in some cases, the manufacturer has received reports of suture breaks resulting in un-retrievable device fragments. although the risk-benefit assessment of further intervention varies from case to case, extensive dissection to attempt removal of retained fragments is typically not recommended. according to the local supplier, the affected products are distributed in hong kong. if you are in possession of the affected products, please contact your supplier for necessary actions. posted on 14 february 2018.

Device

Capio Suture Capturing Devices and Pelvic Floor Kits
  • 모델명 / 제조번호(시리얼번호)
  • 제품 설명
    Medical Device Safety Alert: Boston Scientific Capio Suture Capturing Devices and Pelvic Floor Kits
  • Manufacturer
    Boston Scientific

Manufacturer

Boston Scientific
  • 제조사 모회사 (2017)
    Boston Scientific
  • 제조사 의견
    “We take a patient-first approach to assessing the applicability of every recall and communicate to regulatory bodies in all geographies where the recalled device is sold,” Boston Scientific said in a statement to ICIJ. “We have coordinated several recalls across many countries in a timely manner,” the company said, adding that it complies with all national laws, which can often vary and require different processes for reporting information or taking action on recalls. The company said it uses a rigorous and uniform process to take action on recalls and that “when we initiate a field action (e.g. recall, safety alert), every customer who has received an affected product receives a communication that includes a letter for the physician.”
  • Source
    DH